Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 7.39
+0.10 (1.37%)
Aug 11, 2025, 2:45 PM CST
Ligand Pharmaceuticals Revenue
Wanbangde Pharmaceutical Holding Group had revenue of 315.11M CNY in the quarter ending March 31, 2025, a decrease of -26.58%. This brings the company's revenue in the last twelve months to 1.33B, down -16.18% year-over-year. In the year 2024, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.44B, down -6.39%.
Revenue (ttm)
1.33B
Revenue Growth
-16.18%
P/S Ratio
3.41
Revenue / Employee
886.79K
Employees
1,499
Market Cap
4.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.44B | -98.57M | -6.39% |
| Dec 31, 2023 | 1.54B | -244.49M | -13.69% |
| Jan 1, 2023 | 1.79B | -144.17M | -7.47% |
| Jan 1, 2022 | 1.93B | -11.77B | -85.91% |
| Dec 31, 2020 | 13.70B | -2.99B | -17.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.48B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |